Kingsley invests £10m in Oxford Cannabinoid Technologies
Kingsley Capital Partners has invested £10m in Oxford University spinout Oxford Cannabinoid Technologies (OCT), a developer of medical cannabis-based therapies.
The company will work alongside Oxford University to conduct research and development within the space.
The development comes after Kingsley founded US-based business Forma in 2016, which acquired assets across the cultivation, manufacturing and distribution of medical cannabis. Kingsley managing partner Neil Mahapatra is the president of Forma.
Company
OCT is a therapeutic cannabinoid biotechnology company. The business will develop therapies for acute and chronic conditions including pain, cancer, neurological disorders and inflammatory disease.
People
Kingsley Capital Partners – Neil Mahapatra (managing partner).
More on Buyouts
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Exponent divests ‘significant' stake in Meadow to Canadian investor
Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater